NurOwn® (autologous MSC-NTF cells) in ALS - phase 3 clinical trial update - Ralph Kern

9/24/2020; 14 minutes

Ralph Kern MD MHSc
Brainstorm Cell Therapeutics Recorded on 09/14/2020.
(#36320)

Links & Resources

More Programs With

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2020 Regents of the University of California. All right reserved. Terms and Conditions of Use.